Copay help by condition · Lung and breathing · read 2026-11-10
Asthma: which charitable copay funds are open
All 4 funds we hold for Asthma are closed or at capacity right now (read 2026-11-10).
Funds fill and reopen. Use the alert below, ask the manufacturer's program for your drug (see the assistance finder), and check your state's Medicaid coverage.
If you have Medicare Part D: CMS prints the annual out-of-pocket threshold as $2,400 in 2027 ($2,100 in 2026) (Table V-2 of its CY 2027 announcement). It is a benefit parameter and applies to covered drugs under plan rules. What changes on January 1.
Swipe to read across
A copy for a patient, a clinic or a pharmacist, with each source and the date we read it.
Every fund we hold for Asthma
- WaitlistAsthma
Accessia Health ·
Award level: not statedInsurance supported: not stated
The program page lists the program as At Capacity, Waitlist Open. It shows no date. Source page
- Closed or at capacityAsthma
HealthWell Foundation ·
Award level: not statedInsurance supported: not stated
The page lists the fund as Closed. Source page
- Closed or at capacityAsthma
TotalAssist (Patient Advocate Foundation copay funds) ·
Award level: $3,500Insurance supported: Medicaid, Medicare, TRICARE
The page lists the fund as Closed. Source page
- Closed or at capacityAsthma health equity
TotalAssist (Patient Advocate Foundation copay funds) ·
Award level: $3,500Insurance supported: Medicaid, Medicare, TRICARE
The page lists the fund as Closed. Source page
Drugs whose FDA label names Asthma
10 drugs. Each row quotes the sentence of the drug's FDA label (Indications and Usage, openFDA) that names the condition. A label naming a condition is not a statement that the drug is approved, effective or covered for you. Dashes in quotes are shown as hyphens. Of these, 6 have a program (in our assistance finder or on the program's own page) and 0 have a Medicare negotiated price in the CMS file; an empty cell says we found nothing in our data, not that nothing exists.
| Drug | What the FDA label says | Manufacturer program | Medicare negotiated price |
|---|---|---|---|
| Xolair Omalizumab Every route for this drug | Moderate to severe persistent asthma in adults and pediatric patients 6 years of age and older with a positive skin test or in vitro reactivity to a perennial aeroallergen and symptoms that are inadequately controlled with ... Label on openFDA, read 2026-11-10 | Asthma Medication Assistance (Multiple Programs) Genentech Patient Foundation | selected by CMS for 2028; price not yet published |
| Fasenra Benralizumab Every route for this drug | ... add-on maintenance treatment of adult and pediatric patients aged 6 years and older with severe asthma, and with an eosinophilic phenotype. Label on openFDA, read 2026-11-10 | Asthma Medication Assistance (Multiple Programs) AZ&Me Prescription Savings Program Limited | not in the CMS negotiated-price file |
| Dupixent Dupilumab Every route for this drug | Asthma as an add-on maintenance treatment of adult and pediatric patients aged 6 years and older with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid ... Label on openFDA, read 2026-11-10 | Dupixent MyWay Asthma Medication Assistance (Multiple Programs) | not in the CMS negotiated-price file |
| Arnuity Ellipta Fluticasone Furoate Every route for this drug | ARNUITY ELLIPTA is indicated for the maintenance treatment of asthma in adult and pediatric patients aged 5 years and older. Label on openFDA, read 2026-11-10 | GSK Patient Assistance Program (GSK ViiV Healthcare Patient Access Programs Foundation) (program page) | not in the CMS negotiated-price file |
| Nucala Mepolizumab Every route for this drug | Add-on maintenance treatment of adult and pediatric patients aged 6 years and older with severe asthma and with an eosinophilic phenotype. Label on openFDA, read 2026-11-10 | Asthma Medication Assistance (Multiple Programs) GSK Patient Assistance Program (GSK ViiV Healthcare Patient Access Programs Foundation) (program page) | not in the CMS negotiated-price file |
| Tezspire Tezepelumab-Ekko Every route for this drug | ... for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma. Label on openFDA, read 2026-11-10 | Amgen Safety Net Foundation (program page) | not in the CMS negotiated-price file |
| Albuterol Sulfate HFA, Ventolin HFA Albuterol Sulfate | Albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease). Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
| Budesonide And Formoterol Fumarate Dihydrate Budesonide/Formoterol Fumarate | Treatment of asthma in patients 6 years of age and older. Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
| Flovent Diskus Fluticasone Propionate | FLOVENT DISKUS is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
1 drug whose label names more than 8 conditions
Broad labels, such as corticosteroids, list many conditions in one sentence. They are shown apart so they do not crowd the drugs written for Asthma.
| Drug | What the FDA label says | Manufacturer program | Medicare negotiated price |
|---|---|---|---|
| Acthar Corticotropin | Bronchial asthma; Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
Related conditions
No broader or more specific condition page for this one.
Group: Lung and breathing. All conditions: the condition index. Fund board for every condition: charitable copay fund status.
What changed
First read on 2026-11-10. We keep each read with its date, so a fund reopening or closing will show here as a change. Until we have a second read there is nothing to compare, and we do not guess. The read date of every source is on the changes page.
This page as data
The same facts as JSON, each fund with its source URL and read date: asthma.json. Edition 2026-11, root 006ab9a329709cbe. See the licence page.
Questions
Is there an open charitable copay fund for Asthma?
As read on 2026-11-10, none of the 4 funds we hold for Asthma say they are open. Funds reopen, so use the alert on this page.
Which organizations run funds for Asthma?
Accessia Health, HealthWell Foundation and TotalAssist (Patient Advocate Foundation copay funds). Each fund row on this page links to the organization's own page.
Does an open fund mean I qualify?
No. A status says whether a fund is taking applications. Eligibility, award level and which insurance it supports are each fund's own rules; where the page states them they are shown on the fund.
How current is this page?
Statuses are what each fund's own page said on the date we read it (2026-11-10). We do not promise a fund is still in that state today.